Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kiniksa Pharmaceuticals International (KNSA) Change in Inventory: 2021-2024

Historic Change in Inventory for Kiniksa Pharmaceuticals International (KNSA) over the last 4 years, with Dec 2024 value amounting to -$4.8 million.

  • Kiniksa Pharmaceuticals International's Change in Inventory fell 9.83% to -$6.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $12.7 million, marking a year-over-year increase of 310.59%. This contributed to the annual value of -$4.8 million for FY2024, which is 149.96% down from last year.
  • According to the latest figures from FY2024, Kiniksa Pharmaceuticals International's Change in Inventory is -$4.8 million, which was down 149.96% from $9.5 million recorded in FY2023.
  • Kiniksa Pharmaceuticals International's Change in Inventory's 5-year high stood at $17.9 million during FY2022, with a 5-year trough of -$4.8 million in FY2024.
  • Moreover, its 3-year median value for Change in Inventory was $9.5 million (2023), whereas its average is $7.6 million.
  • Its Change in Inventory has fluctuated over the past 5 years, first spiked by 387.73% in 2022, then crashed by 149.96% in 2024.
  • Yearly analysis of 4 years shows Kiniksa Pharmaceuticals International's Change in Inventory stood at $3.7 million in 2021, then soared by 387.73% to $17.9 million in 2022, then slumped by 46.87% to $9.5 million in 2023, then tumbled by 149.96% to -$4.8 million in 2024.